Used in pharmaceutical research as a key intermediate in the synthesis of potent dopamine D3 receptor antagonists. Its structural complexity allows for high selectivity toward D3 receptors, making it valuable in developing treatments for neurological disorders such as schizophrenia, Parkinson’s disease, and substance use disorders. The compound's chiral centers and ester functionality enable further chemical modifications, facilitating structure-activity relationship studies. It is also employed in the preparation of bioactive molecules targeting central nervous system diseases due to its ability to cross the blood-brain barrier effectively.